Targeting hardship: poverty as a modifiable risk factor in childhood leukemia and lymphoma treatment DOI
Puja J. Umaretiya, Rahela Aziz‐Bose, Colleen Kelly

et al.

Hematology, Journal Year: 2024, Volume and Issue: 2024(1), P. 20 - 26

Published: Dec. 6, 2024

Racial, ethnic, and socioeconomic survival disparities have been well-demonstrated across population-based clinical trial datasets in pediatric hematologic malignancies. To date, these analyses relied on trial-collected data such as race, ethnicity, insurance, zip code. These exposures serve proxies for factors structural racism, genetic ancestry, adverse social determinants of health (SDOH). Systematic measurement SDOH needs-and interventions targeting needs-are feasible oncology. We use to present a roadmap the next decade equity research identify actionable mechanisms develop portfolio advance equitable outcomes

Language: Английский

The impact of Indigenous American-like ancestry on risk of acute lymphoblastic leukemia in Hispanic/Latino children DOI Creative Commons
Jalen Langie, Tsz Fung Chan, Wenjian Yang

et al.

medRxiv (Cold Spring Harbor Laboratory), Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 15, 2025

Abstract Acute lymphoblastic leukemia (ALL) is the most common childhood cancer, with Hispanic/Latino children having a higher incidence of ALL than other racial/ethnic groups. Genetic variants, particularly ones found enriched in Indigenous American (IA)-like ancestry and inherited by Hispanics/Latinos, may contribute to this disparity. In study, we characterized impact IA-like on overall risk frequency effect size known alleles large cohort self-reported individuals. We also performed genome-wide admixture mapping analysis identify potentially novel loci. that global IA was positively associated risk, but association not significant after adjusting for socio-economic indicators. series local analyses, uncovered at loci, increasing copies haplotype were significantly case-control status. Further, had ∼1.33 times odds harboring allele compared non-IA-like haplotypes. no evidence interaction between genotype (local or global) relation risk. Admixture identified signals chromosomes 2 (2q21.2), 7 (7p12.2), 10 (10q21.2), 15 (15q22.31); however, only variants 7p12.2 10q21.2 replicated additional cohorts. Taken together, our results suggest increased be conferred within ancestry, which can leveraged as targets new precision health strategies therapeutics.

Language: Английский

Citations

0

Trends and Disparities in Acute Lymphoblastic Leukemia–Related Mortality in the United States from 1999 to 2020 DOI
Shahzaib Ahmed, Eeman Ahmad, Hamza Ashraf

et al.

American Journal of Clinical Oncology, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 31, 2025

Objectives: The incidence of acute lymphoblastic leukemia (ALL) shows a bimodal distribution, with the first peak in children under 10 years old and second adults. It is imperative to understand disparities ALL-related mortality. Methods: mortality trends United States from 1999 2020 were studied by extracting age-adjusted rates (AAMRs) Centers for Disease Control Prevention Wide-Ranging Online Data Epidemiologic Research database. Changes AAMR evaluated calculating annual percentage change (APC) average APC using Joinpoint regression. Results: A total 35,056 deaths reported. declined (APC: −0.65). Men exhibited higher (0.59) than women (0.43). Hispanic or Latinos highest (0.75), followed non-Hispanic (NH) whites (0.47), NH black African Americans (0.37), Asian Pacific Islanders (0.35). Among census regions, West was observed have (0.59), South (0.49), Midwest Northeast (0.45). California had (0.64), while District Columbia lowest (0.40). Stratification urbanization revealed overall rural areas (0.52) urban (0.48). majority occurred medical facilities (63.52%). Conclusions: Even though decrease 2020, identified stratified sex, race, urbanization. essential direct efforts towards high-risk populations ensure across board.

Language: Английский

Citations

0

Evolution, genetic diversity, and health DOI Creative Commons
María J. Palma-Martínez, Yuridia S. Posadas‐García, Amara Shaukat

et al.

Nature Medicine, Journal Year: 2025, Volume and Issue: unknown

Published: March 7, 2025

Language: Английский

Citations

0

Childhood B cell leukemia: Intercepting the paths to progression DOI Creative Commons
César Cobaleda, Carolina Vicente‐Dueñas, Kim E. Nichols

et al.

BioEssays, Journal Year: 2024, Volume and Issue: 46(9)

Published: July 26, 2024

Abstract B‐cell Acute Lymphoblastic Leukemia (B‐ALL) is the most common pediatric cancer, arising often in children aged 2–5 years. This distinctive age distribution hints at an association between B‐ALL development and disrupted immune system function during a susceptible period childhood, possibly triggered by early exposure to infection. While cure rates for childhood surpass 90% high‐income nations, survivors suffer from diminished quality of life due side effects treatment. Consequently, understanding origins evolution B‐ALL, how prevent this prevalent paramount alleviate substantial health burden. article provides overview our current etiology explores knowledge can inform preventive strategies.

Language: Английский

Citations

0

Ikaros Deletions among Bulgarian Patients with Acute Lymphoblastic Leukemia/Lymphoma DOI Creative Commons
Stefan Lozenov,

Yoanna Tsoneva,

Georgi Nikolaev

et al.

Diagnostics, Journal Year: 2024, Volume and Issue: 14(17), P. 1953 - 1953

Published: Sept. 3, 2024

The

Language: Английский

Citations

0

Targeting hardship: poverty as a modifiable risk factor in childhood leukemia and lymphoma treatment DOI
Puja J. Umaretiya, Rahela Aziz‐Bose, Colleen Kelly

et al.

Hematology, Journal Year: 2024, Volume and Issue: 2024(1), P. 20 - 26

Published: Dec. 6, 2024

Racial, ethnic, and socioeconomic survival disparities have been well-demonstrated across population-based clinical trial datasets in pediatric hematologic malignancies. To date, these analyses relied on trial-collected data such as race, ethnicity, insurance, zip code. These exposures serve proxies for factors structural racism, genetic ancestry, adverse social determinants of health (SDOH). Systematic measurement SDOH needs-and interventions targeting needs-are feasible oncology. We use to present a roadmap the next decade equity research identify actionable mechanisms develop portfolio advance equitable outcomes

Language: Английский

Citations

0